Epidural/spinal anesthesia during delivery in women with factor XI deficiency, a single center experience.


Journal

Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 19 01 2020
revised: 25 05 2020
accepted: 26 05 2020
pubmed: 16 7 2020
medline: 6 8 2021
entrez: 16 7 2020
Statut: ppublish

Résumé

The safety of neuro-axial anaesthesia (epidural/spinal) at labour of women with partial factor XI (FXI) deficiency is uncertain. Although FXI deficiency is frequent in Ashkenazi Jews, it is not routinely measured before labour. Our institute serves a large Ashkenazi population. We assumed that 10% of them have undiagnosed FXI deficiency. Assess the incidence, bleeding tendency and coagulation status among Jewish Ashkenazi women with FXI deficiency that underwent neuro-axial anaesthesia at delivery. Jewish Ashkenazi women who underwent neuro-axial anaesthesia at labour completed the SSC ISTH bleeding assessment tool (BAT) and had blood drawn for coagulation tests, FXI and thrombin generation after labour. Estimation for 10 years was calculated from the 1-year sample. We recruited 261 women during 12 months. Among them, 39 (15%) had FXI deficiency (<70%) with median FXI levels of 63% (range: 33%-70%). Around 50% of them underwent amniocentesis in the current pregnancy and prior neuro-axial anaesthesia with no bleeding complications. BAT score and thrombin generation did not differ between women regardless of FXI status. aPTT was longer in women with partial FXI deficiency (median - 28.6 sec vs 26.3 sec, P < .001, Table 2), although within the normal range in all women. No bleeding complications after neuro-axial anaesthesia at delivery were reported in our centre in the last decade though, and according to our estimation, at least 2150 women had partial FXI deficiency. A significant number of Jewish Ashkenazi women with undiagnosed partial FXI deficiency undergo neuro-axial anaesthesia at labour without bleeding complications.

Identifiants

pubmed: 32666626
doi: 10.1111/hae.14079
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

834-839

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Asselta R, Paraboschi EM, Rimoldi V, et al. Exploring the global landscape of genetic variation in coagulation factor XI deficiency. Blood. 2017;130(4):e1-e6.
Mannucci PM, Tuddenham EG. The hemophilias-from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773-1779.
Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014;167(3):304-326.
Seligsohn U. High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood. 1978;51(6):1223-1228.
Shpilberg O, Peretz H, Zivelin A, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood. 1995;85(2):429-432.
Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham EG. Definition of the bleeding tendency in factor XI-deficient kindreds-a clinical and laboratory study. Thromb Haemost. 1995;73(2):194-202.
Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood. 1985;65(3):719-724.
Santoro C, Di Mauro R, Baldacci E, et al. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre. Haemophilia. 2015;21(4):496-501.
Agarwal A, Kishore K. Complications and controversies of regional anaesthesia: a review. Indian J Anaesth. 2009;53(5):543-553.
Rosero EB, Joshi GP. Nationwide incidence of serious complications of epidural analgesia in the United States. Acta Anaesthesiol Scand. 2016;60(6):810-820.
Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology. 2004;101(4):950-959.
Davies J, Kadir R. The management of factor XI deficiency in pregnancy. Semin Thromb Hemost. 2016;42(7):732-740.
Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063-2065.
Elbatarny M, Mollah S, Grabell J, et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831-835.
Beilin Y, Katz DJ. Factor XI deficiency: the key is individualization. Anesth Analg. 2019;128(1):e10-e19.
Shander A, Friedman T, Palleschi G, Shore-Lesserson L. The evolving dilemma of factor XI in pregnancy: suggestions for management. Anesth Analg. 2018;126(6):2032-2037.
Reuveni A, Orbach-Zinger S, Eidelman LA, Ginosar Y, Ioscovich A. Peripartum anesthetic management of patients with Factor XI deficiency. J Perinat Med. 2014;42(3):295-300.
Duga S, Salomon O. Congenital factor XI deficiency: an update. Semin Thromb Hemost. 2013;39(6):621-631.
Kadir RA, Economides DL, Lee CA. Factor XI deficiency in women. Am J Hematol. 1999;60(1):48-54.
Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004;114(5-6):409-414.
Management of inherited bleeding disorders in pregnancy: green-top guideline No. 71 (joint with UKHCDO). BJOG. 2017;124(8):e193-e263.
Verghese L, Tingi E, Thachil J, Hay C, Byrd L. Management of parturients with factor XI deficiency-10 year case series and review of literature. Eur J Obstet Gynecol Reprod Biol. 2017;215:85-92.
Setty S, Reddell A, England A, Gomez K, Kadir R. The role of recombinant factor VIIa for obstetric block in women with severe factor XI deficiency. Haemophilia. 2011;17(6):906-909.
Bolton-Maggs PH. Factor XI deficiency-resolving the enigma? Hematology. 2009;2009:97-105.

Auteurs

Adi Shacham Abulafia (A)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yuval Yaniv (Y)

Helen Schneider Hospital for Women, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

Arza Steimatzky (A)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

Sharon Orbach-Zinger (S)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Anesthesia, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

Eran Hadar (E)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Helen Schneider Hospital for Women, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

Anat Shmueli (A)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Helen Schneider Hospital for Women, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

Adi Borovich (A)

Helen Schneider Hospital for Women, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

Ester Ziv (E)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

Uri Rozovski (U)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Arnon Wiznitzer (A)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Helen Schneider Hospital for Women, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

Leonid A Eidelman (LA)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Anesthesia, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

Pia Raanani (P)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Galia Spectre (G)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH